T2D - managing CVD risk factors

Date Published: 
Wednesday, March 9, 2022

Rinki Murphy outlines the practical strategies GPs can put in place to enable systematic CVD risk factor management among patients with T2D.



  • 00:01 Intro
  • 00:40 What percentage does CVD risk increase by  for the T2D patient?
  • 04:29 What is the underlying mechanism at play here?
  • 05:35 Helping to mitigate this risk?
  • 07:33 Universal screening - how often?
  • 11:39 SGLT2i/GLP1RA - What is the data supporting their use?
  • 16:40 Is the trial data correct?
  • 17:49 CVD risk reduction - which class is most beneficial?
  • 19:10 Monitoring – what to be aware of?
  • 22:13 Sick day management – criteria for stopping and starting?
  • 23:24 Take-home messages


Take-home messages

  • Not all patients with T2D have the same high level of CVD risk.
  • Use the updated CVD risk prediction tool.
  • Use either SGLT2i or the GLP1RA early in T2D patients with CVD risk above 15%
  • Blood pressure reduction (ABCD memory aid)
  • Patient education a support is key.




Rinki Murphy
Diabetes Physician

Rinki is a Diabetes Physician at Auckland DHB and Counties Manukau Health. Rinki is an Associate Professor in Medicine at the University of Auckland and Principle investigator at the Maurice Wilkins Centre for Biodiscovery. She is a diabetologist at Auckland and Counties Manukau DHB.


This episode is kindly supported by an educational grant from Eli Lilly.

Recognition of Learning Activities

Complete and submit the learning reflection form for CPD/MOPS points provided by The Royal New Zealand College of General Practitioners below for recognition of learning activities.

Learning Reflection Form


This presentation is intended for qualified health practitioners professional development and should not be relied upon for any other purpose. Any opinions offered are those of the presenter or other speaker and do not necessarily represent the views of Goodfellow Unit.